Skip to main content

Interwest Venture Management Co

SEC CIK
0001697720
Latest filing
Oct 20, 2023

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Jan 31, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
5
−3 vs. Q3 2022
Portfolio value
$20.8M
−$11.6M (−35.9%) vs. Q3 2022
Filed
Jan 31, 2023
SEC
Holdings of Interwest Venture Management Co in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
PMVPPMV Pharmaceuticals, Inc.COM1,614,911$14.0M67.5%00.0%UnchangedHistory
SERASera Prognostics, Inc.CLASS A COM2,416,241$3.04M14.6%00.0%UnchangedHistory
REALTheRealReal, Inc.COM2,354,080$2.94M14.1%00.0%UnchangedHistory
GKOSGLAUKOS CorpCOM16,347$714.0K3.4%00.0%UnchangedHistory
DAREDare Bioscience, Inc.COM62,065$51.5K0.2%00.0%UnchangedHistory

Sold out since Q3 2022 (3)

Positions held at the end of Q3 2022 that are gone from this filing.

Positions of Interwest Venture Management Co sold out since Q3 2022
SecurityClassShares in Q3 2022Value in Q3 2022% of portfolio in Q3 2022History
EIGREiger BioPharmaceuticals, Inc.COM560,990$4.22M13.0%History
AGTCApplied Genetic Technologies CorpCOM1,404,515$381.0K1.2%History
VEROVenus Concept Inc.COM658,657$290.0K0.9%History